Moody Aldrich Partners LLC Edgewise Therapeutics, Inc. Transaction History
Moody Aldrich Partners LLC
- $425 Million
- Q1 2025
A detailed history of Moody Aldrich Partners LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 182,095 shares of EWTX stock, worth $3.01 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
182,095
Previous 187,932
3.11%
Holding current value
$3.01 Million
Previous $5.02 Million
20.15%
% of portfolio
0.94%
Previous 1.06%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
221Shares Held
98.7MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$248 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$147 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$102 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$99.5 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$82.7 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.04B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...